Ann LaCasce, MD, a medical oncologist in the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answered a variety of questions about Hodgkin and non-Hodgkin lymphoma during a live web chat hosted by Dana-Farber last month.
The chat, which featured questions submitted by patients and live viewers, focused on new treatments for lymphoma. Some of the topics discussed included new drugs Ibrutinib and Brentuximab, use of umbilical cord stem cells, and treatments with genetically engineered T-cells.
“There are some questions we still have, but I think the work around T-cells is a very exciting area in lymphoma, and it’s going to have applications in other cancers as well,” LaCasce said.
View a video of the Dec. 18 web chat below. For more information on lymphoma, visit the Dana-Farber Adult Lymphoma Program website.